Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Veracyte Inc (NASDAQ:VCYT)

7.89
Delayed Data
As of 3:59pm ET
 -0.16 / -1.99%
Today’s Change
4.21
Today|||52-Week Range
8.48
+1.94%
Year-to-Date
No recent news for Veracyte Inc.

Today’s Trading

Previous close8.05
Today’s open8.11
Day’s range7.75 - 8.20
Volume55,098
Average volume (3 months)137,533
Market cap$264.6M
Dividend yield--
Data as of 3:59pm ET, 02/23/2017

Growth & Valuation

Earnings growth (last year)+4.41%
Earnings growth (this year)+5.77%
Earnings growth (next 5 years)--
Revenue growth (last year)+29.62%
P/E ratioNM
Price/Sales3.78
Price/Book4.35

Competitors

 Today’s
change
Today’s
% change
OXFDOxford Immunotec Glo...+0.19+1.43%
CALACalithera Bioscience...-0.20-2.27%
QTNTQuotient Ltd-0.05-0.78%
TRIBTrinity Biotech PLC0.000.00%
Data as of 4:00pm ET, 02/23/2017

Financials

Next reporting dateMarch 16, 2017
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$49.5M
Annual profit (last year)-$33.7M
Net profit margin-68.08%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Bonnie H. Anderson
Chief Operating Officer
Christopher M. Hall
Corporate headquarters
South San Francisco, California

Forecasts


Search for Jobs